297 related articles for article (PubMed ID: 34862606)
1. The potential of gene therapy for recessive dystrophic epidermolysis bullosa.
Subramaniam KS; Antoniou MN; McGrath JA; Lwin SM
Br J Dermatol; 2022 Apr; 186(4):609-619. PubMed ID: 34862606
[TBL] [Abstract][Full Text] [Related]
2. Mutation analysis and molecular genetics of epidermolysis bullosa.
Pulkkinen L; Uitto J
Matrix Biol; 1999 Feb; 18(1):29-42. PubMed ID: 10367729
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hereditary epidermolysis bullosa: updates and future prospects.
Hsu CK; Wang SP; Lee JY; McGrath JA
Am J Clin Dermatol; 2014 Feb; 15(1):1-6. PubMed ID: 24402870
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
Cutlar L; Greiser U; Wang W
Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073
[TBL] [Abstract][Full Text] [Related]
5. Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa.
So JY; Nazaroff J; Iwummadu CV; Harris N; Gorell ES; Fulchand S; Bailey I; McCarthy D; Siprashvili Z; Marinkovich MP; Tang JY; Chiou AS
Orphanet J Rare Dis; 2022 Oct; 17(1):377. PubMed ID: 36253825
[TBL] [Abstract][Full Text] [Related]
6. Eye Involvement and Management in Inherited Epidermolysis Bullosa.
Bachir Y; Daruich A; Marie C; Robert MP; Bremond-Gignac D
Drugs; 2022 Aug; 82(12):1277-1285. PubMed ID: 36074321
[TBL] [Abstract][Full Text] [Related]
7. Inherited epidermolysis bullosa dystrophica and squamous cell carcinoma- A case report.
Gayathri E; Anbukkarasi K; Lilly SM
Indian J Pathol Microbiol; 2023; 66(2):360-362. PubMed ID: 37077084
[TBL] [Abstract][Full Text] [Related]
8. Epidermolysis bullosa and cancer.
Mallipeddi R
Clin Exp Dermatol; 2002 Nov; 27(8):616-23. PubMed ID: 12472531
[TBL] [Abstract][Full Text] [Related]
9. Squamous Cell Carcinoma in Patients with Inherited Epidermolysis Bullosa: Review of Current Literature.
Bonamonte D; Filoni A; De Marco A; Lospalluti L; Nacchiero E; Ronghi V; Colagrande A; Giudice G; Cazzato G
Cells; 2022 Apr; 11(8):. PubMed ID: 35456044
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous Squamous Cell Carcinoma in Epidermolysis Bullosa: a 28-year Retrospective Study.
Robertson SJ; Orrin E; Lakhan MK; O'Sullivan G; Felton J; Robson A; Greenblatt DT; Bernardis C; McGrath JA; Martinez AE; Mellerio JE
Acta Derm Venereol; 2021 Aug; 101(8):adv00523. PubMed ID: 34230977
[TBL] [Abstract][Full Text] [Related]
11. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa.
Tang JY; Marinkovich MP; Lucas E; Gorell E; Chiou A; Lu Y; Gillon J; Patel D; Rudin D
Orphanet J Rare Dis; 2021 Apr; 16(1):175. PubMed ID: 33849616
[TBL] [Abstract][Full Text] [Related]
12. Epidermolysis Bullosa: Pediatric Perspectives.
Hon KL; Chu S; Leung AKC
Curr Pediatr Rev; 2022; 18(3):182-190. PubMed ID: 34036913
[TBL] [Abstract][Full Text] [Related]
13. Molecular therapies for inherited epidermolysis bullosa.
Has C
G Ital Dermatol Venereol; 2016 Aug; 151(4):397-402. PubMed ID: 27149615
[TBL] [Abstract][Full Text] [Related]
14. Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa.
Kim M; Murrell DF
Eur J Dermatol; 2015 Apr; 25 Suppl 1():30-2. PubMed ID: 26083672
[TBL] [Abstract][Full Text] [Related]
15. Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives.
Condorelli AG; Dellambra E; Logli E; Zambruno G; Castiglia D
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739489
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-145-5p regulates fibrotic features of recessive dystrophic epidermolysis bullosa skin fibroblasts.
Condorelli AG; Logli E; Cianfarani F; Teson M; Diociaiuti A; El Hachem M; Zambruno G; Castiglia D; Odorisio T
Br J Dermatol; 2019 Nov; 181(5):1017-1027. PubMed ID: 30816994
[TBL] [Abstract][Full Text] [Related]
17. Electrochemotherapy, a local treatment for squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.
Bartolo J; Farricha V; Carvalhal S; Moura C; Abecasis N
Dermatol Ther; 2020 Nov; 33(6):e14093. PubMed ID: 32720460
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America.
Feinstein JA; Jambal P; Peoples K; Lucky AW; Khuu P; Tang JY; Lara-Corrales I; Pope E; Wiss K; Hook KP; Levin LE; Morel KD; Paller AS; McCuaig CC; Powell J; Eichenfield LF; Price H; Levy ML; Schachner LA; Browning JC; Bayliss S; Jahnke M; Shwayder T; Glick SA; Bruckner AL
JAMA Dermatol; 2019 Feb; 155(2):196-203. PubMed ID: 30586139
[TBL] [Abstract][Full Text] [Related]
19. Inherited epidermolysis bullosa: new diagnostic criteria and classification.
Intong LR; Murrell DF
Clin Dermatol; 2012; 30(1):70-7. PubMed ID: 22137229
[TBL] [Abstract][Full Text] [Related]
20. Premature termination codons in the type VII collagen gene (COL7A1) underlie severe, mutilating recessive dystrophic epidermolysis bullosa.
Christiano AM; Anhalt G; Gibbons S; Bauer EA; Uitto J
Genomics; 1994 May; 21(1):160-8. PubMed ID: 8088783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]